Medical specialists from France tagged as investigators in clinical trials studying Familial Primary Pulmonary Hypertension

Total 77 results

Adrien JANKOWSKI, MD
Seen in:
- Grenoble, Hôpital Nord de Grenoble
Trials:
- NCT02579954 (Principal Investigator)
Conditions:
- Pulmonary Arterial Hypertension
Alain Lebon
Seen in:
- Basse-Normandie, Caen, Caen UH
Trials:
- NCT01905189 (Sub-Investigator)
Conditions:
- Pulmonary Arterial Hypertension
Anne-Sophie GAMEZ-DUBUIS, MD
Seen in:
- Montpellier, CHU de Montpellier
Trials:
- NCT02579954 (Sub-Investigator)
Conditions:
- Pulmonary Arterial Hypertension
Antoine BEURNIER, MD
Seen in:
- Paris, APHP - Hôpital Bicêtre
Trials:
- NCT02579954 (Sub-Investigator)
Conditions:
- Pulmonary Arterial Hypertension
Ari Chaouat, PhD
Seen in:
- Meurthe Et Moselle, Vandoeuvre les Nancy, CHU Nancy - Hôpital de Brabois Adultes, Pneumologie- Oncologie Médicale, Rue du Morvan
Trials:
- NCT03626688 (Principal Investigator)
Conditions:
Armelle SCHULLER, MD
Seen in:
- Strasbourg, CHRU de Strasbourg
Trials:
- NCT02579954 (Sub-Investigator)
Conditions:
- Pulmonary Arterial Hypertension
Arnaud Bourdin, MD
Seen in:
- Montpellier, CHU de Montpellier
- Montpellier, Hôpital Arnaud de Villeneuve
Trials:
- NCT05557942 (Principal Investigator)
- NCT04517916 (Principal Investigator)
- NCT05036135 (Principal Investigator)
- NCT02579954 (Principal Investigator)
Conditions:
- Pulmonary Arterial Hypertension;
- Emphysema or COPD
Arnaud Pellissier
Seen in:
- Basse-Normandie, Caen, Caen UH
Trials:
- NCT01905189 (Sub-Investigator)
Conditions:
- Pulmonary Arterial Hypertension
Berangere Coltey
Seen in:
- Marseille, Hôpital Nord - CHU Marseille
Trials:
- NCT03626688 (Principal Investigator)
Conditions:
Bernard WUYAM, MD
Seen in:
- Grenoble, Hôpital Nord de Grenoble
- La Tronche, Grenoble, University Grenoble Hospital
Trials:
- NCT03014609 (Sub-Investigator)
- NCT02579954 (Sub-Investigator)
Conditions:
- Chronic Obstructive Pulmonary Disease;
- Pulmonary Arterial Hypertension
Bruno DEGANO, MD
Seen in:
- Grenoble, Hôpital Nord de Grenoble
Trials:
- NCT02579954 (Sub-Investigator)
Conditions:
- Pulmonary Arterial Hypertension
Cécile L'HEVEDER, MD
Seen in:
- Brest, CHU de Brest
Trials:
- NCT02579954 (Sub-Investigator)
Conditions:
- Pulmonary Arterial Hypertension
Cécile TROMEUR, MD
Seen in:
- Brest, CHU de Brest
Trials:
- NCT02579954 (Sub-Investigator)
Conditions:
- Pulmonary Arterial Hypertension
Christophe GUT-GOBERT, MD
Seen in:
- Brest, CHU de Brest
Trials:
- NCT02579954 (Sub-Investigator)
Conditions:
- Pulmonary Arterial Hypertension
Christophe PISON, MD
Seen in:
- Grenoble, Hôpital Nord de Grenoble
Trials:
- NCT02579954 (Sub-Investigator)
Conditions:
- Pulmonary Arterial Hypertension
Claire DAUPHIN, MD
Seen in:
- Clermont Ferrand, Chu Gabriel Montpied
- Clermont-Ferrand, Chu Clermont-Ferrand
Trials:
- NCT02579954 (Principal Investigator)
- NCT02800941 (Principal Investigator)
Conditions:
- Pulmonary Arterial Hypertension
Clément BOISSIN, MD
Seen in:
- Montpellier, Arnaud de villeneuve Hospital
- Montpellier, CHU de Montpellier
Trials:
- NCT03810482 (Sub-Investigator)
- NCT02579954 (Sub-Investigator)
Conditions:
- Hypertension, Pulmonary;
- Pulmonary Arterial Hypertension
Clément DEUDON, MD
Seen in:
- Lyon, HCL - Hôpital Louis Pradel
- Lyon, Hospices Civils de Lyon
Trials:
- NCT02579954 (Sub-Investigator)
- NCT02800941 (Sub-Investigator)
Conditions:
- Pulmonary Arterial Hypertension
Damien Bonnet, Prof
Seen in:
- Paris, Necker-Enfants Malades Hospital, Paris
Trials:
- NCT06350032 (Principal Investigator)
Conditions:
- Pulmonary Arterial Hypertension
David MONTANI, MD
Seen in:
- Paris, APHP - Hôpital Bicêtre
Trials:
- NCT02579954 (Principal Investigator)
Conditions:
- Pulmonary Arterial Hypertension
Emmanuel Bergot
Seen in:
- Basse-Normandie, Caen, Caen UH
- Calvados, Caen Cedex, Centre Hospitalier Universitaire (CHU) de Caen - Hopital Cote de Nacre
Trials:
- NCT01905189 (Sub-Investigator)
- NCT04712669 (Principal Investigator)
Conditions:
- Pulmonary Arterial Hypertension
Eric Saloux
Seen in:
- Basse-Normandie, Caen, Caen UH
Trials:
- NCT01905189 (Sub-Investigator)
Conditions:
- Pulmonary Arterial Hypertension
Evelyne LONSDORFER, MD
Seen in:
- Strasbourg, CHRU de Strasbourg
Trials:
- NCT02579954 (Sub-Investigator)
Conditions:
- Pulmonary Arterial Hypertension
Fabien Labombarda
Seen in:
- Basse-Normandie, Caen, Caen UH
Trials:
- NCT01905189 (Sub-Investigator)
Conditions:
- Pulmonary Arterial Hypertension
Fabrice Bauer
Seen in:
- Rouen, CHU Rouen
- Seine Maritime, Rouen cedex, CHU de Rouen - Hôpital Charles Nicolle
Trials:
- NCT03626688 (Principal Investigator)
- NCT04768322 (Principal Investigator)
Conditions:
Fares Gouzi, MD
Seen in:
- Montpellier, CHU Montpellier
- Montpellier, CHU de Montpellier
Trials:
- NCT02579954 (Sub-Investigator)
- NCT03885765 (Sub-Investigator)
Conditions:
- Pulmonary Arterial Hypertension;
- Non-small Cell Lung Cancer
Farzin Beygui
Seen in:
- Basse-Normandie, Caen, Caen UH
Trials:
- NCT01905189 (Sub-Investigator)
Conditions:
- Pulmonary Arterial Hypertension
Francis Couturaud
Seen in:
- Brest cedex 2, CHU de Brest - Hôpital de la Cavale Blanche
Trials:
- NCT03626688 (Principal Investigator)
Conditions:

Clinical Trials on Familial Primary Pulmonary Hypertension

Bayer

Completed

Post-Marketing Surveillance of Ventavis® in Chinese Patients With Primary Pulmonary Hypertension (PPH)

Primary Hypertension

China
Papworth Hospital NHS Foundation Trust
Merck Sharp & Dohme LLC

Completed

Serum Bio-markers in Pulmonary Hypertension

Pulmonary Hypertension, Primary, 4

United Kingdom
National Taiwan University Hospital

Unknown

Genetic Research of Bone Morphogenetic Protein Receptor-II Gene in Taiwanese Patient With Primary Pulmonary Hypertension

Pulmonary Hypertension

Taiwan
Heidelberg University
Merck Sharp & Dohme LLC

Recruiting

Effects of Riociguat on RIght VEntricular Size and Function in PAH and CTEPH (RIVERII)

Chronic Thromboembolic Pulmonary Hypertension | Primary Pulmonary Arterial Hypertension

Germany
University of South Florida

Withdrawn

Efficacy Study of Cardizem in Pulmonary Arterial Hypertension

Pulmonary Arterial Hypertension | Familial Primary Pulmonary Hypertension | Idiopathic Pulmonary Arterial Hypertension | Primary Pulmonary Hypertension

United States
Boehringer Ingelheim

Completed

Safety and Efficacy of Terbogrel in Patients With Primary Pulmonary Hypertension

Hypertension, Pulmonary
Boehringer Ingelheim

Terminated

Safety of Terbogrel in Patients With Primary Pulmonary Hypertension

Hypertension, Pulmonary
United Therapeutics

Completed

Phase III Randomized Study of UT-15 in Patients With Primary Pulmonary Hypertension

Pulmonary Hypertension

United States
Bayer

Completed

Observation of Patients With Primary Pulmonary Hypertension Receiving Prescribed Ventavis Inhalation Therapy Regarding Safety and Efficacy for up to 4 Years

Hypertension, Pulmonary

Italy, Spain, France, Germany, Portugal, United Kingdom
Liquidia Technologies, Inc.
Nuventra, Inc.

Active, not recruiting

Extension Study for Participants in LIQ861 Trials to Evaluate the Long-term Safety of Dry Powder Inhalation of Treprostinil

Primary Pulmonary Hypertension

United States

Medical specialists from France tagged as investigators in clinical trials studying Familial Primary Pulmonary Hypertension

Clinical Trials on Familial Primary Pulmonary Hypertension

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Spain

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations